HepG2 cells acquire stem cell-like characteristics after immune cell stimulation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HepG2 cells acquire stem cell-like characteristics after immune cell stimulation
Authors
Keywords
Cancer stem cells, HepG2 cells, Splenic B cells, Peritoneal macrophage cells
Journal
CELLULAR ONCOLOGY
Volume 39, Issue 1, Pages 35-45
Publisher
Springer Nature
Online
2015-12-11
DOI
10.1007/s13402-015-0249-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Notch Pathway Activity Identifies Cells with Cancer Stem Cell-like Properties and Correlates with Worse Survival in Lung Adenocarcinoma
- (2013) K. A. Hassan et al. CLINICAL CANCER RESEARCH
- Host–microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer
- (2013) Shirin Moossavi et al. Expert Review of Clinical Immunology
- Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells
- (2013) Yuewen Chang et al. TUMOR BIOLOGY
- Clinical application of circulating tumor cells in breast cancer
- (2013) Leonie H. A. Broersen et al. CELLULAR ONCOLOGY
- Lung cancer stem cells: a biological and clinical perspective
- (2013) Ana Koren et al. CELLULAR ONCOLOGY
- The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
- (2013) Jiabo Di et al. CELLULAR ONCOLOGY
- TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells
- (2012) Sung Hee Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting a cornerstone of radiation resistance: Cancer stem cell
- (2012) Coralie Moncharmont et al. CANCER LETTERS
- GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft
- (2012) Junsheng Fu et al. CANCER LETTERS
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
- (2012) Yi Chen et al. International Journal of Biological Sciences
- Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
- (2012) Hee Yi et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Companies hope for rare win with cancer stem cell therapies
- (2012) Anna Azvolinsky NATURE MEDICINE
- Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis
- (2012) Sheelu Varghese et al. PLoS One
- Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines
- (2011) O. Felthaus et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
- (2011) T. S. Zhu et al. CANCER RESEARCH
- Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway
- (2011) María Rosario García Campelo et al. Clinical & Translational Oncology
- Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics
- (2011) Su-Ni Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of Inflammatory Factors on Mesenchymal Stem Cells and Their Role in the Promotion of Tumor Angiogenesis in Colon Cancer
- (2011) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Power and the Promise of Liver Cancer Stem Cell Markers
- (2011) Li-Li Liu et al. STEM CELLS AND DEVELOPMENT
- New hope in the horizon: cancer stems cells
- (2010) S. Bhattacharyya et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- City of hope cancer center hematology-oncology fellowship and hematopoietic stem cell transplantation fellowship
- (2010) Amrita Krishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
- (2010) M. F. Shi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The stability of breast cancer progenitor cells during cryopreservation: Maintenance of proliferation, self-renewal, and senescence characteristics
- (2010) Feridoun Karimi-Busheri et al. CRYOBIOLOGY
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- Cancer stem cells: a model in the making
- (2009) Lauren L Campbell Marotta et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Endomorphin-suppressed nitric oxide release from mice peritoneal macrophages
- (2009) Tihomir Balog et al. NEUROPEPTIDES
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
- (2008) Eric D. Hsi et al. LEUKEMIA & LYMPHOMA
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
- (2008) S. Ma et al. MOLECULAR CANCER RESEARCH
- New hope for cancer treatment: Exploring the distinction between normal adult stem cells and cancer stem cells
- (2008) Robert Chunhua Zhao et al. PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started